Floatz logo

METHOTREXATE

Conditioning Therapy

The First Affiliated Hospital of Soochow UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

10 Active assets in the Conditioning Therapy cohort.

Asset / SponsorPhaseRating
Bendamustine
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2B
Azacitidine
The First Affiliated Hospital of Soochow University
Phase 2CCC
Anti-Thymoglobulin, Rabbit
The First Affiliated Hospital of Soochow University
Phase 2CCC
Cytosin-Arabinosid
The First Affiliated Hospital of Soochow University
Phase 2CCC
UREA, N-(2-CHLOROETHYL)-N'-(4-METHYLCYCLOHEXYL)-N-NITROSO-
The First Affiliated Hospital of Soochow University
Phase 2CCC

View all 11 →

Same molecule, other indications

METHOTREXATE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
acute promyelocytic leukemiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →